Soon thereafter, it became apparent that antigen binding site restrictions was a feature of the CLL BcR IG repertoire beyond IGHV3-21 expressing cases: indeed, a sizeable fraction of unrelated CLL patients were assigned to subsets characterized by highly similar, “stereotyped” VH CDR3 sequences. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.